Stay updated on CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial
Sign up to get notified when there's something new on the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page.

Latest updates to the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page footer shows a revision update from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed.SummaryDifference0.1%

- Check24 days agoChange DetectedRemoved the government funding lapse notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check38 days agoChange DetectedNo significant changes detected in the page content or structure; the study information remains consistent with the prior version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check67 days agoChange Detected- Added a new page revision tag: v3.2.0. - Removed the specific resource entry: Genetic and Rare Diseases Information Center resources: Ovarian cancer. - Also indicates a prior revision tag: v3.0.2.SummaryDifference0.4%

- Check82 days agoChange DetectedThe page update mainly adds v3.0.2 as the new revision and removes the previous v3.0.1, removing a 'Back to Top' element. Overall, this is a minor version bump with negligible impact on core content or functionality.SummaryDifference0.2%

Stay in the know with updates to CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page.